Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

13.1K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
13.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dopaminergic nigrostriatal vulnerability in Parkinson's Disease with diabetes: evidence from severity-matched cohorts.

European journal of nuclear medicine and molecular imaging·2026
Same author

A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer's disease.

Acta neuropathologica·2026
Same author

The Impact of Insulin Resistance on Grey Matter Changes Along the Alzheimer's Disease Continuum Insulin Resistance and Grey Matter in AD.

medRxiv : the preprint server for health sciences·2025
Same author

Nuclear Alpha-Synuclein: Mechanisms and Implications for Synucleinopathies.

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Pharmacogenetics in advanced Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996)·2025
Same author

Loss of the lysosomal protein CLN3 triggers c-Abl-dependent YAP1 pro-apoptotic signaling.

EMBO reports·2025
Same journal

Correction: Reis et al. Bioinks Enriched with ECM Components Obtained by Supercritical Extraction. <i>Biomolecules</i> 2022, <i>12</i>, 394.

Biomolecules·2026
Same journal

Correction: Kim, K.-H.; Yoo, B.C. Gintonin as a Lysophosphatidic Acid-Enriched GPCR Ligand System: Molecular Architecture and Receptor Pharmacology in <i>Panax ginseng</i>. <i>Biomolecules</i> 2026, <i>16</i>, 465.

Biomolecules·2026
Same journal

Correction: Bastyte et al. The Association of Vitamin D Receptor Gene Polymorphisms with Vitamin D, Total IgE, and Blood Eosinophils in Patients with Atopy. <i>Biomolecules</i> 2024, <i>14</i>, 212.

Biomolecules·2026
Same journal

AtHSPR Plays a Positive Role in Arabidopsis Resistance Against <i>Pseudomonas syringae</i> pv. <i>tomato</i> DC3000 by Interacting with TOP1.

Biomolecules·2026
Same journal

CYTH4 Facilitates Renal Cell Carcinoma via Enhancing Proliferation and Likely Immune Evasion.

Biomolecules·2026
Same journal

Integrated Immune-Gut Profiling Identifies an Exploratory Pediatric Inflammatory Intestinal Profile Associated with Food-Specific IgG Reactivity.

Biomolecules·2026
See all related articles

Related Experiment Video

Updated: Apr 14, 2026

Technique for Intranasal Administration of &#945;-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

1.2K

The Interplay between Alpha-Synuclein Clearance and Spreading.

Tomás Lopes da Fonseca1,2, Anna Villar-Piqué3, Tiago Fleming Outeiro4,5,6

  • 1Department of Neurodegeneration and Restorative Research, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, University Medical Center Göttingen, Göttingen 37073, Germany. tlopesdafonseca@gmail.com.

Biomolecules
|April 16, 2015
PubMed
Summary
This summary is machine-generated.

Parkinson's Disease involves alpha-synuclein (α-syn) aggregation and spread. Impaired protein degradation may lead to α-syn release, driving pathology progression and offering therapeutic targets.

More Related Videos

Detection of Disease-associated &#945;-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated &#945;-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.4K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.3K

Related Experiment Videos

Last Updated: Apr 14, 2026

Technique for Intranasal Administration of &#945;-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

1.2K
Detection of Disease-associated &#945;-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated &#945;-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.4K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.3K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Parkinson's Disease (PD) is a neurodegenerative disorder marked by movement issues, dopaminergic neuron loss, and alpha-synuclein (α-syn) inclusions.
  • Evidence suggests α-syn pathology spreads in a prion-like manner, contributing to disease progression.

Purpose of the Study:

  • To review the relationship between α-syn degradation pathways and its intercellular spread in Parkinson's Disease.
  • To highlight the importance of understanding these mechanisms for developing new therapeutic strategies.

Main Methods:

  • Literature review of studies on α-syn degradation and intercellular transfer.
  • Analysis of the interplay between cellular protein clearance mechanisms and α-syn pathology.

Main Results:

  • Intracellular α-syn homeostasis relies on chaperone-mediated autophagy, macroautophagy, and the ubiquitin-proteasome system.
  • Impaired degradation may promote α-syn release, facilitating extracellular spread and propagation.

Conclusions:

  • Understanding the interplay between α-syn degradation and intercellular spread is crucial for elucidating Parkinson's Disease mechanisms.
  • This knowledge is vital for designing novel therapeutic interventions targeting α-syn pathology.